1. Home
  2. SDHI vs NPCE Comparison

SDHI vs NPCE Comparison

Compare SDHI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDHI
  • NPCE
  • Stock Information
  • Founded
  • SDHI 2024
  • NPCE 1997
  • Country
  • SDHI United States
  • NPCE United States
  • Employees
  • SDHI N/A
  • NPCE N/A
  • Industry
  • SDHI Blank Checks
  • NPCE Medical Specialities
  • Sector
  • SDHI Finance
  • NPCE Health Care
  • Exchange
  • SDHI Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • SDHI 354.0M
  • NPCE 363.2M
  • IPO Year
  • SDHI 2025
  • NPCE 2021
  • Fundamental
  • Price
  • SDHI $10.24
  • NPCE $10.62
  • Analyst Decision
  • SDHI
  • NPCE Strong Buy
  • Analyst Count
  • SDHI 0
  • NPCE 6
  • Target Price
  • SDHI N/A
  • NPCE $16.67
  • AVG Volume (30 Days)
  • SDHI 121.5K
  • NPCE 116.7K
  • Earning Date
  • SDHI 01-01-0001
  • NPCE 11-04-2025
  • Dividend Yield
  • SDHI N/A
  • NPCE N/A
  • EPS Growth
  • SDHI N/A
  • NPCE N/A
  • EPS
  • SDHI N/A
  • NPCE N/A
  • Revenue
  • SDHI N/A
  • NPCE $88,570,000.00
  • Revenue This Year
  • SDHI N/A
  • NPCE $22.13
  • Revenue Next Year
  • SDHI N/A
  • NPCE $6.07
  • P/E Ratio
  • SDHI N/A
  • NPCE N/A
  • Revenue Growth
  • SDHI N/A
  • NPCE 23.32
  • 52 Week Low
  • SDHI $10.00
  • NPCE $6.03
  • 52 Week High
  • SDHI $10.45
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • SDHI N/A
  • NPCE 53.23
  • Support Level
  • SDHI N/A
  • NPCE $10.42
  • Resistance Level
  • SDHI N/A
  • NPCE $11.14
  • Average True Range (ATR)
  • SDHI 0.00
  • NPCE 0.48
  • MACD
  • SDHI 0.00
  • NPCE -0.06
  • Stochastic Oscillator
  • SDHI 0.00
  • NPCE 42.97

About SDHI Siddhi Acquisition Corp Class A Common stock

Siddhi Acquisition Corp is a blank check company.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: